Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|December 14, 2019
Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancerIveta Kolarova, Jaroslav Vanasek, Karel Odrazka, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 30, 2015
Interfraction variation in prostate cancer - analysis of 11726 cone-beam CTMartin Dolezel, Peter Slezak, Karel Odrazka, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|November 23, 2019
Giant locally advanced and metastatic squamous cell skin carcinoma of head and neck region: case reportJan Stuk, Jaroslav Vanasek, Karel Odrazka, et al.
Urologia Internationalis|October 27, 2010
Radical prostatectomy in high-grade prostate cancer, salvage and adjuvant radiotherapyMilos Brodak, Josef Kosina, Lukas Holub, et al.
Oncology Reports|September 6, 2005
Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?Karel Odrazka, Miloslava Vaculikova, Martin Dolezel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 16, 2015
Comparing morbidity and cancer control after 3D-conformal (70/74 Gy) and intensity modulated radiotherapy (78/82 Gy) for prostate cancerMartin Dolezel, Karel Odrazka, Milan Zouhar, et al.
International Journal of Radiation Oncology, Biology, Physics|February 4, 2012
MRI-based preplanning using CT and MRI data fusion in patients with cervical cancer treated with 3D-based brachytherapy: feasibility and accuracy studyMartin Dolezel, Karel Odrazka, Jan Zizka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 26, 2003
Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancerKarel Odrazka, Miloslava Vaculikova, Jiri Petera, et al.
Pageof 3